CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Korea Arlico Pharm Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Korea Arlico Pharm Co Ltd
Korea Arlico Pharm Bildg.
7-21, Baumoe-ro 27-gil, Seocho-gu
Phone: +82 805850004p:+82 805850004 SEOUL, 06752  South Korea Ticker: 260660260660
Business Summary
Korea Arlico Pharm Co Ltd is a Korea-based company engaged in the manufacturing and sales of medicines business. The Company manufactures and sells medicines such as hyperlipidemia, cerebrovascular disease, digestive medicine, allergies, respiratory medicine and others. In addition, the Company is also engaged in the manufacture of non-pharmaceutical products such as sun cream, hand cream and medical devices. The Company sells its products in domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Jae HuiChoi 53 2/28/2019 2/28/2019
Vice President Sun EonHong 77
Assistant Managing Director Ha YeonCho 56
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 229 (As of 6/30/2025)
Outstanding Shares: 15,013,391 (As of 6/30/2025)
Shareholders: 9,590
Stock Exchange: KDQ
Fax Number: +82 25875199


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, October 31, 2025